Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

112.90 USD +1.60 (+1.44%)
Streaming Delayed Price Updated: 10:17 AM EST, Jan 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
74 75 Next >
Abbott Hosts Conference Call for Third-Quarter Earnings
Abbott (NYSE: ABT) will announce its third-quarter 2019 financial results on Wednesday, Oct. 16, 2019, before the market opens. 
From PR Newswire
Abbott Announces European Approval of Two Life-saving Heart Devices for Babies and Children
- World's smallest pediatric treatments pioneered by Abbott address critical needs for the most vulnerable patients: babies and children born with common congenital heart defects 
From PR Newswire
Abbott Named the Industry Leader in Sustainability for the Seventh Consecutive Year on the Dow Jones Sustainability Index (DJSI)
- Abbott achieves top scores across all three key areas of economic, social and environmental performance, earns more than double the average score in Health Care Equipment & Supplies industry sector 
From PR Newswire
Abbott and Sanofi Partner to Integrate Glucose Sensing and Insulin Delivery Technologies to Help Change the Way Diabetes is Managed
- Collaboration aims to provide a connected device experience for millions of people living with diabetes using insulin 
From PR Newswire
Abbott's Revolutionary FreeStyle® Libre System Now Reimbursed in the Two Largest Provinces in Canada
Abbott (NYSE: ABT), the global leader in sensor-based glucose monitoring, announced today that it has received public reimbursement in Ontario and Quebec for its FreeStyle® Libre system, becoming the... 
From PR Newswire
Abbott Declares 383rd Consecutive Quarterly Dividend
The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 32 cents per share. 
From PR Newswire
Advances in Biotechnology May Offer Cancer Patients Renewed Hope
FinancialBuzz.com News Commentary 
From PR Newswire
Abbott Announces New Data That Shows Artificial Intelligence Technology Can Help Doctors Better Determine Which Patients are Having a Heart Attack
- New research found Abbott's algorithm created through machine learning could give doctors a more individualized calculation, leveraging factors such as age, sex and the changing dynamics of troponin... 
From PR Newswire
Ministry of Health of Rwanda, Society for Family Health Rwanda and Abbott Launch Pioneering Model of Primary Health Care Service Delivery in Rwanda
- New initiative will provide vital primary care services within a 30-minute walk of all Rwandans' homes 
From PR Newswire
He's Back and He's Hydrated: Abbott and NFL Star Odell Beckham Jr. Partner for Pedialyte®
- Beckham will serve as spokesperson and creative director for Pedialyte 
From PR Newswire
Abbott Launches World's First Pivotal Trial to Test New Approach for Repairing Leaky Tricuspid Heart Valves
- TRILUMINATE Pivotal trial is the world's first randomized clinical trial to evaluate transcatheter tricuspid valve repair in patients with severe tricuspid regurgitation 
From PR Newswire
Surmodics Completes Enrollment in Pivotal TRANSCEND Clinical Trial
Surmodics has completed enrollment in TRANSCEND, its pivotal clinical trial for the SurVeil™ drug-coated balloon. 
From Business Wire News Releases
New Study Finds Abbott's Blood Test Technology Could Help Detect Brain Injury Quickly, Even if CT Scan is Normal
- The TRACK-TBI study found that 64% of people with the highest levels of a protein in the blood were confirmed to have brain injury through an MRI scan, even when a CT scan did not detect it 
From PR Newswire
Together, We Can Increase the Number of Women in STEM: Here is a Tool to Help Companies Get Started
- On Women's Equality Day, Abbott is publishing a blueprint for creating a high school STEM internship aimed at exposing young people, particularly girls, to STEM early and empowering other companies... 
From PR Newswire
Abbott and Intoximeters Partner to Keep Roads Safer by Bringing Together Industry-leading Technology for Drug and Alcohol Testing
- Agreement gives law enforcement access to the most advanced handheld tools to help detect drug and alcohol-impaired drivers 
From PR Newswire
Absolute Reports Fiscal 2019 Fourth Quarter and Annual Financial Results
Absolute (TSX: ABT) (“Absolute” or the “Company”), the leader in endpoint resilience, today announced its financial results for the three months and year ended June 30, 2019. All dollar figures are... 
From Business Wire News Releases
Absolute Names Lynn Atchison to Board of Directors
Absolute (TSX: ABT), the leader in endpoint resilience, today announced Lynn Atchison has joined Absolute's Board of Directors effective as of August 7, 2019. Ms. Atchison will also serve on the Audit... 
From Business Wire News Releases
Absolute to Host Conference Call for Fiscal 2019 Fourth Quarter and Annual Financial Results
Absolute (TSX: ABT), the leader in endpoint resilience, today announced it will host a conference call on Tuesday, August 13, 2019 at 5:00 ET (2:00 p.m. PT) to discuss its fiscal 2019 fourth quarter... 
From Business Wire News Releases
Absolute Announces Significant Updates to its Enterprise Resilience Edition, Simplifying Security Policy Deployments and Remote Management of Device Fleets
Absolute (TSX: ABT), the leader in endpoint resilience, today announced the latest update to its Enterprise Resilience Edition. The new release provides customers with increased operational efficiency,... 
From Business Wire News Releases
Absolute Declares Quarterly Dividend
Absolute (TSX: ABT), the leader in endpoint resilience, today announced that its Board of Directors has declared a quarterly dividend of CAD$0.08 per share on its common shares, payable in cash on... 
From Business Wire News Releases
Biotech Brief: Acute Myeloid Leukemia Market to Reach $1.5 Billion Dollars by 2024
Financialnewsmedia.com News Commentary 
From PR Newswire
Biotech Brief: Acute Myeloid Leukemia Market To Reach $1.5 Billion Dollars By 2024
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Abbott Reports Second-Quarter 2019 Results
- Accelerated and sustainable growth driven by strong performance across portfolio 
From PR Newswire
Abbott Receives U.S. Approval of Next-Generation MitraClip®, Bringing New Enhancements to Abbott's Leading MitraClip Platform
- U.S. approval for MitraClip G4 offers a next-generation approach to mitral valve repair 
From PR Newswire
Abbott Announces FDA Approval of the Alinity™ s System, the Latest Technology for Screening and Protecting the U.S. Blood and Plasma Supply
- Alinity™ s System will screen the U.S. blood and plasma supply faster and more efficiently while maintaining highest levels of accuracy 
From PR Newswire
Nutrition Is the Missing Ingredient in Home Health Today, New Study Shows
- Real-world data from Advocate Health Care and Abbott shows prioritizing nutrition care for home health patients helped keep them out of the hospital 
From PR Newswire
Abbott Hosts Conference Call for Second-Quarter Earnings
Abbott (NYSE: ABT) will announce its second-quarter 2019 financial results on Wednesday, July 17, 2019, before the market opens. 
From PR Newswire
CARE, Abbott and the Abbott Fund Launch Partnership to Address Noncommunicable Diseases (NCDs) in Humanitarian Settings
- Program focused on helping people affected by conflict in Marawi City, Philippines 
From PR Newswire
Abbott Launches First-ever Rapid Point-of-Care HbA1c Test to Aid in the Diagnosis of Diabetes
- Afinion™ HbA1c Dx test provides results in three minutes, enabling clinicians to develop informed, individualized care plans during patient consultation 
From PR Newswire
Abbott Declares 382ⁿᵈ Consecutive Quarterly Dividend
The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 32 cents per share. 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
74 75 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.